Use of 2,7-diamino-1,2,3,4-tetrahydronaphthalenes as medicaments, new 2,7-diamino-1,2,3,4-tetrahydronaphthalenes and processes for their preparation

US5053430A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Matthias Grauert · Ingelheim am Rhein, DE
• Herbert Merz · Ingelheim am Rhein, DE
• Joachim Mierau · Mainz, DE
• Gunter Schingnitz · Bad Kreuznach, DE
• Claus Schneider · Ingelheim am Rhein, DE

Key dates

• Filing date: Sep 22, 1989
• Grant date: Oct 1, 1991
• Expiry date: Sep 22, 2009

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Novel compounds having the general formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined herein. These compounds are useful in the treatment of schizophrenia.